Page last updated: 2024-08-17

levodopa and quetiapine fumarate

levodopa has been researched along with quetiapine fumarate in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (5.00)	18.2507
2000's	13 (65.00)	29.6817
2010's	5 (25.00)	24.3611
2020's	1 (5.00)	2.80

Authors

Authors	Studies
Fernandez, HH; Friedman, JH; Jacques, C; Rosenfeld, M	1
Minagar, A; Shulman, LM; Weiner, WJ	1
Burke, MA; Fernandez, HH; Friedman, JH; Trieschmann, ME	1
Factor, SA; Feustel, PJ; Molho, ES; Reddy, S	1
Bibbiani, F; Chase, TN; Oh, JD	1
Cossu, G; Floris, G; Hayflick, SJ; Melis, M; Spissu, A	1
Burke, MA; Fernandez, HH; Friedman, JH; Jacques, C; Trieschmann, ME	1
Kodama, R; Kondo, T; Miwa, H; Morita, S	1
Baron, MS; Dalton, WB	1
Evans, A; Katzenschlager, R; Lees, AJ; Manson, AJ; Watt, H	1
Evatt, ML; Jewart, RD; Jou, HC; Juncos, JL; Potter, LS; Roberts, VJ; Wood, CD; Yeung, PP	1
Jung, SK	1
Baltuch, GH; Chou, KL; Hurtig, HI; Jaggi, JL; Pelchat, RJ; Weintraub, D	1
Schindehütte, J; Trenkwalder, C	1
Heinz, A; Majic, T; Mell, T; Rapp, MA	1
Bentivoglio, AR; Fasano, A; Pettorruso, M; Ricciardi, L	1
Arai, H; Doi, N; Hatta, K; Hattori, N; Kamigaichi, R; Kubo, S; Nakamura, H; Nakanishi, A; Usui, C	1
Inoue, M; Inoue, Y; Kishimoto, T; Kiuchi, K; Kosaka, J; Morikawa, M; Norimoto, K	1
Gambini, O; Islam, L; Piacentini, S; Scarone, S; Soliveri, P	1
Alakkas, A; Liu, L; Longardner, K; Nahab, FB; Wright, BA; Xu, R; You, H	1

Trials

6 trial(s) available for levodopa and quetiapine fumarate

Article	Year
Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:3 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Brief Psychiatric Rating Scale; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Quetiapine Fumarate; Severity of Illness Index	1999
Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:6 Topics: Aged; Antipsychotic Agents; Dibenzothiazepines; Humans; Levodopa; Lewy Body Disease; Parkinson Disease; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Quetiapine Fumarate; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2002
Quetiapine as treatment for dopaminergic-induced dyskinesias in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:10 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dibenzothiazepines; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Quetiapine Fumarate	2003
Low dose quetiapine for drug induced dyskinesias in Parkinson's disease: a double blind cross over study. Journal of neurology, neurosurgery, and psychiatry, 2004, Volume: 75, Issue:2 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Cross-Over Studies; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Quetiapine Fumarate	2004
Quetiapine improves psychotic symptoms and cognition in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:1 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Brief Psychiatric Rating Scale; Delusions; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hallucinations; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Psychoses, Substance-Induced; Quetiapine Fumarate	2004
Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Aug-15, Volume: 35, Issue:7 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Clinical Trials, Phase I as Topic; Dibenzothiazepines; Disease Progression; Electroconvulsive Therapy; Electroencephalography; Female; Humans; Inpatients; Levodopa; Male; Middle Aged; Parkinson Disease; Psychotic Disorders; Quetiapine Fumarate; Regional Blood Flow; Risk Factors; Time Factors; Tokyo; Tomography, Emission-Computed, Single-Photon	2011

Other Studies

14 other study(ies) available for levodopa and quetiapine fumarate

Article	Year
Quetiapine for l-dopa-induced psychosis in PD. Neurology, 2000, Apr-11, Volume: 54, Issue:7 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Humans; Levodopa; Male; Olanzapine; Parkinson Disease; Pirenzepine; Psychoses, Substance-Induced; Quetiapine Fumarate; Treatment Outcome	2000
The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:4 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Psychoses, Substance-Induced; Quetiapine Fumarate; Retrospective Studies	2002
Quetiapine attenuates levodopa-induced motor complications in rodent and primate parkinsonian models. Experimental neurology, 2002, Volume: 177, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antipsychotic Agents; Behavior, Animal; Dibenzothiazepines; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Quetiapine Fumarate; Rats; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists	2002
Hallervorden Spatz syndrome (pantothenate kinase associated neurodegeneration) in two Sardinian brother with homozygous mutation in PANK 2 gene. Journal of neurology, 2002, Volume: 249, Issue:11 Topics: Adult; Dibenzothiazepines; Female; Globus Pallidus; Homozygote; Humans; Italy; Levodopa; Magnetic Resonance Imaging; Male; Mutation, Missense; Pantothenate Kinase-Associated Neurodegeneration; Phosphotransferases (Alcohol Group Acceptor); Quetiapine Fumarate	2002
Long-term outcome of quetiapine use for psychosis among Parkinsonian patients. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:5 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Dibenzothiazepines; Drug Tolerance; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Male; Outcome Assessment, Health Care; Parkinson Disease; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Severity of Illness Index	2003
[Three patients with Parkinson's disease whose therapeutic levels were successfully improved after administration of quetiapine for suppression of psychosis]. No to shinkei = Brain and nerve, 2003, Volume: 55, Issue:5 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Cabergoline; Dibenzothiazepines; Ergolines; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Quetiapine Fumarate	2003
A young onset Parkinson's patient: a case study. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 2004, Volume: 36, Issue:5 Topics: Activities of Daily Living; Adult; Age of Onset; Amantadine; Antiparkinson Agents; Carbidopa; Combined Modality Therapy; Deep Brain Stimulation; Dibenzothiazepines; Disease Progression; Dyskinesias; Humans; Levodopa; Male; Motor Skills; Nurse's Role; Parkinson Disease; Patient Advocacy; Patient Education as Topic; Quality of Life; Quetiapine Fumarate; Rhabdomyolysis; Severity of Illness Index; Social Support; Treatment Outcome	2004
Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators. Parkinsonism & related disorders, 2005, Volume: 11, Issue:6 Topics: Antiparkinson Agents; Antipsychotic Agents; Deep Brain Stimulation; Depressive Disorder, Major; Dibenzothiazepines; Electroconvulsive Therapy; Female; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease; Quetiapine Fumarate; Subthalamic Nucleus	2005
Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing. Clinical neurology and neurosurgery, 2007, Volume: 109, Issue:2 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Laughter; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinson Disease, Secondary; Piperazines; Psychoses, Substance-Induced; Quetiapine Fumarate; Thiazoles	2007
Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome. International psychogeriatrics, 2010, Volume: 22, Issue:4 Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Clozapine; Delusions; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Levodopa; Lewy Body Disease; Neuroleptic Malignant Syndrome; Quetiapine Fumarate; Severity of Illness Index	2010
Management of punding in Parkinson's disease: an open-label prospective study. Journal of neurology, 2011, Volume: 258, Issue:4 Topics: Adult; Aged; Algorithms; Amantadine; Antipsychotic Agents; Dibenzothiazepines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Quetiapine Fumarate; Stereotypic Movement Disorder	2011
Parkinsonism with multiple cysts in the bilateral striata. Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2011, Volume: 11, Issue:3 Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Antipsychotic Agents; Brain Ischemia; Delirium; Delusions; Diagnosis, Differential; Dibenzothiazepines; Dominance, Cerebral; Drug Therapy, Combination; Encephalomalacia; Hallucinations; Humans; Levodopa; Magnetic Resonance Imaging; Male; Neostriatum; Neurologic Examination; Organophosphate Poisoning; Parkinsonian Disorders; Psychoses, Substance-Induced; Quetiapine Fumarate; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	2011
Capgras delusion for animals and inanimate objects in Parkinson's Disease: a case report. BMC psychiatry, 2015, Apr-08, Volume: 15 Topics: Animals; Antiparkinson Agents; Antipsychotic Agents; Capgras Syndrome; Carbidopa; Clozapine; Cognitive Dysfunction; Delusions; Dibenzothiazepines; Dogs; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Levodopa; Parkinson Disease; Pets; Plants; Quetiapine Fumarate	2015
Assessing the risks of treatment in Parkinson disease psychosis: An in-depth analysis. PloS one, 2023, Volume: 18, Issue:1 Topics: Aged; Antipsychotic Agents; Dementia; Humans; Levodopa; Parkinson Disease; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Urea	2023